Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Author:

Luo Huiyan12,Lu Jin3,Bai Yuxian4,Mao Teng5,Wang Jun6,Fan Qingxia7,Zhang Yiping8,Zhao Kuaile9,Chen Zhendong10,Gao Shegan11,Li Jiancheng12,Fu Zhichao13,Gu Kangsheng14,Liu Zhihua15,Wu Lin16,Zhang Xiaodong17,Feng Jifeng18,Niu Zuoxing19,Ba Yi20,Zhang Helong21,Liu Ying22,Zhang Li23,Min Xuhong24,Huang Jing25,Cheng Ying26,Wang Dong27,Shen Yu28,Yang Qing28,Zou Jianjun28,Xu Rui-Hua12,Yuan Xianglin29,Ma Dong29,Liu Li29,Ye Feng29,Liu Tianshu29,Wang Xiuwen29,Liu Likun29,Xia Bing29,Ran Fengming29,Sun Sanyuan29,Miao Zhanhui29,Bie Jun29,Gao Yong29,Yu Junyan29,Chen Li29,He Yifu29,Ren Wei29,Luo Suxia29,Zhao Guangqiang29,Lin Youen29,Chen Long29,Guo Zhiyuan29,Hu Chunhong29,Wang Ying29,Xu Nong29,Chen Baofu29,Zhan Xianbao29,Chen Yuping29,Lu Hongda29,Qin Shukui29,Wang Guolei29,Chen Liming29,Bai Li29,Zhang Jingdong29,

Affiliation:

1. Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

2. Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, China

3. Sichuan Cancer Hospital, Chengdu, China

4. Harbin Medical University Cancer Hospital, Harbin, China

5. Shanghai Chest Hospital, Shanghai, China

6. The Fourth Hospital of Hebei Medical University, Shijiazhuang, China

7. The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

8. Zhejiang Cancer Hospital, Hangzhou, China

9. Fudan University Shanghai Cancer Center, Shanghai, China

10. The Second Affiliated Hospital of Anhui Medical University, Hefei, China

11. The First Affiliated Hospital of Henan University of Science & Technology, Luoyang, China

12. Fujian Provincial Cancer Hospital, Fuzhou, China

13. 900 Hospital of the Joint Logistics Support Force, Fuzhou, China

14. The First Affiliated Hospital of Anhui Medical University, Hefei, China

15. Jiangxi Provincial Cancer Hospital, Nanchang, China

16. Hunan Cancer Hospital, Changsha, China

17. Peking University Cancer Hospital and Institute, Beijing, China

18. Jiangsu Cancer Hospital, Nanjing, China

19. Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China

20. Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

21. The Second Affiliated Hospital of Air Force Medical University, Xi'an, China

22. Henan Cancer Hospital, Zhengzhou, China

23. Chongqing Three Gorges Central Hospital, Chongqing, China

24. Anhui Chest Hospital, Hefei, China

25. Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China

26. Jilin Cancer Hospital, Changchun, China

27. Army Medical Center of PLA, Chongqing, China

28. Jiangsu Hengrui Pharmaceuticals Co, Ltd, Shanghai, China

29. for the ESCORT-1st Investigators

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 404 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3